Chondroitin Sulphate: a Focus on Osteoarthritis

Overview

Journal Glycoconj J

Publisher Springer

Specialties Biochemistry
Endocrinology

Date 2016 May 20

PMID 27194526

Citations 56

Authors

Mamta Bishnoi

Ankit Jain

Pooja Hurkat

Sanjay K Jain

Affiliations

Soon will be listed here.

Abstract

Chondroitin sulfate (CS) being a natural glycosaminoglycan is found in the cartilage and extracellular matrix. It shows clinical benefits in symptomatic osteoarthritis (OA) of the finger, knee, hip joints, low back, facial joints and other diseases due to its anti-inflammatory activity. It also helps in OA by providing resistance to compression, maintaining the structural integrity, homeostasis, slows breakdown and reduces pain in sore muscles. It is most often used in combination with glucosamine to treat OA. CS is a key role player in the regulation of cell development, cell adhesion, proliferation, and differentiation. Its commercial applications have been continuously explored in the engineering of biological tissues and its combination with other biopolymers to formulate scaffolds which promote and accelerate the regeneration of damaged structure. It is approved in the USA as a dietary supplement for OA, while it is used as a symptomatic slow-acting drug (SYSADOA) in Europe and some other countries. Any significant side effects or overdoses of CS have not been reported in clinical trials suggesting its long-term safety. This review highlights the potential of CS, either alone or in combination with other drugs, to attract the scientists engaged in OA treatment and management across the world.

Citing Articles

Porcine-Derived Chondroitin Sulfate Sodium Alleviates Osteoarthritis in HTB-94 Cells and MIA-Induced SD Rat Models.

Kim H, Kim J, Park S, Kim J, Gwon Y, Lee M Int J Mol Sci. 2025; 26(2).

PMID: 39859238 PMC: 11764645. DOI: 10.3390/ijms26020521.

Expanding the recognition of monosaccharides and glycans: A comprehensive analytical approach using chemical-nose/tongue technology and a comparison to lectin microarrays.

Tomita S, Nagai-Okatani C BBA Adv. 2025; 7():100129.

PMID: 39790466 PMC: 11714387. DOI: 10.1016/j.bbadva.2024.100129.

Effects of the oral administration of glycosaminoglycans with or without native type II collagen on the articular cartilage transcriptome in an osteoarthritic-induced rabbit model.

Marine-Casado R, Domenech-Coca C, Fernandez S, Costa A, Segarra S, Lopez-Andreo M Genes Nutr. 2024; 19(1):19.

PMID: 39232650 PMC: 11375882. DOI: 10.1186/s12263-024-00749-2.

Semi-synthetic chondroitin sulfate CS-semi5 upregulates miR-122-5p, conferring a therapeutic effect on osteoarthritis the p38/MMP13 pathway.

Li X, Zhou Y, Chen X, Wang H, Yang S, Yang J Acta Pharm Sin B. 2024; 14(8):3528-3542.

PMID: 39220883 PMC: 11365380. DOI: 10.1016/j.apsb.2024.05.016.

The Effectiveness of a Single Hyaluronic Acid Injection in Improving Symptoms and Muscular Strength in Patients with Knee Osteoarthritis: A Multicenter, Retrospective Study.

Tarantino D, Forte A, Picone A, Sirico F, Ruosi C J Pers Med. 2024; 14(8).

PMID: 39201976 PMC: 11355087. DOI: 10.3390/jpm14080784.

References

Luo X, Fosmire G, Leach Jr R . Chicken keel cartilage as a source of chondroitin sulfate. Poult Sci. 2002; 81(7):1086-9. DOI: 10.1093/ps/81.7.1086. View

Schneider H, Maheu E, Cucherat M . Symptom-modifying effect of chondroitin sulfate in knee osteoarthritis: a meta-analysis of randomized placebo-controlled trials performed with structum(®). Open Rheumatol J. 2012; 6:183-9. PMC: 3412198. DOI: 10.2174/1874312901206010183. View

Smiley S, King J, Hancock W . Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4. J Immunol. 2001; 167(5):2887-94. DOI: 10.4049/jimmunol.167.5.2887. View

Du J, White N, Eddington N . The bioavailability and pharmacokinetics of glucosamine hydrochloride and chondroitin sulfate after oral and intravenous single dose administration in the horse. Biopharm Drug Dispos. 2004; 25(3):109-16. DOI: 10.1002/bdd.392. View

Bara J, Johnson W, Caterson B, Roberts S . Articular cartilage glycosaminoglycans inhibit the adhesion of endothelial cells. Connect Tissue Res. 2011; 53(3):220-8. DOI: 10.3109/03008207.2011.629310. View

Steenvoorden M, Bank R, Ronday H, Toes R, Huizinga T, Degroot J . Fibroblast-like synoviocyte-chondrocyte interaction in cartilage degradation. Clin Exp Rheumatol. 2007; 25(2):239-45. View

Midwood K, Sacre S, Piccinini A, Inglis J, Trebaul A, Chan E . Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease. Nat Med. 2009; 15(7):774-80. DOI: 10.1038/nm.1987. View

Liu X, Sun C, Zang H, Wang W, Guo R, Wang F . Capillary electrophoresis for simultaneous analysis of heparin, chondroitin sulfate and hyaluronic acid and its application in preparations and synovial fluid. J Chromatogr Sci. 2012; 50(5):373-9. DOI: 10.1093/chromsci/bms015. View

Bishnoi M, Jain A, Hurkat P, Jain S . Aceclofenac-loaded chondroitin sulfate conjugated SLNs for effective management of osteoarthritis. J Drug Target. 2014; 22(9):805-12. DOI: 10.3109/1061186X.2014.928714. View

10.

Ogawa H, Hatano S, Sugiura N, Nagai N, Sato T, Shimizu K . Chondroitin sulfate synthase-2 is necessary for chain extension of chondroitin sulfate but not critical for skeletal development. PLoS One. 2012; 7(8):e43806. PMC: 3429490. DOI: 10.1371/journal.pone.0043806. View

11.

Bedini E, De Castro C, De Rosa M, Di Nola A, Restaino O, Schiraldi C . Semi-synthesis of unusual chondroitin sulfate polysaccharides containing GlcA(3-O-sulfate) or GlcA(2,3-di-O-sulfate) units. Chemistry. 2012; 18(7):2123-30. DOI: 10.1002/chem.201102458. View

12.

Nandini C, Itoh N, Sugahara K . Novel 70-kDa chondroitin sulfate/dermatan sulfate hybrid chains with a unique heterogeneous sulfation pattern from shark skin, which exhibit neuritogenic activity and binding activities for growth factors and neurotrophic factors. J Biol Chem. 2004; 280(6):4058-69. DOI: 10.1074/jbc.M412074200. View

13.

Calamia V, Lourido L, Fernandez-Puente P, Mateos J, Rocha B, Montell E . Secretome analysis of chondroitin sulfate-treated chondrocytes reveals anti-angiogenic, anti-inflammatory and anti-catabolic properties. Arthritis Res Ther. 2012; 14(5):R202. PMC: 3580514. DOI: 10.1186/ar4040. View

14.

Schiraldi C, Cimini D, De Rosa M . Production of chondroitin sulfate and chondroitin. Appl Microbiol Biotechnol. 2010; 87(4):1209-20. DOI: 10.1007/s00253-010-2677-1. View

15.

Jomphe C, Gabriac M, Hale T, Heroux L, Trudeau L, deBlois D . Chondroitin sulfate inhibits the nuclear translocation of nuclear factor-kappaB in interleukin-1beta-stimulated chondrocytes. Basic Clin Pharmacol Toxicol. 2007; 102(1):59-65. DOI: 10.1111/j.1742-7843.2007.00158.x. View

16.

Avachat A, Kotwal V . Design and evaluation of matrix-based controlled release tablets of diclofenac sodium and chondroitin sulphate. AAPS PharmSciTech. 2008; 8(4):E88. PMC: 2750558. DOI: 10.1208/pt0804088. View

17.

Sobal G, Dorotka R, Menzel J, Sinzinger H . Uptake studies with chondrotropic 99mTc-chondroitin sulfate in articular cartilage. Implications for imaging osteoarthritis in the knee. Nucl Med Biol. 2013; 40(8):1013-7. DOI: 10.1016/j.nucmedbio.2013.07.007. View

18.

Jain A, Gulbake A, Shilpi S, Jain A, Hurkat P, Jain S . A new horizon in modifications of chitosan: syntheses and applications. Crit Rev Ther Drug Carrier Syst. 2013; 30(2):91-181. DOI: 10.1615/critrevtherdrugcarriersyst.2013005678. View

19.

Martel-Pelletier J, Roubille C, Abram F, Hochberg M, Dorais M, Delorme P . First-line analysis of the effects of treatment on progression of structural changes in knee osteoarthritis over 24 months: data from the osteoarthritis initiative progression cohort. Ann Rheum Dis. 2013; 74(3):547-56. DOI: 10.1136/annrheumdis-2013-203906. View

20.

Homandberg G, Hui F . Association of proteoglycan degradation with catabolic cytokine and stromelysin release from cartilage cultured with fibronectin fragments. Arch Biochem Biophys. 1996; 334(2):325-31. DOI: 10.1006/abbi.1996.0461. View